More Merck KGaA Info

Merck KGaA could receive buyout interest for its generic drugs business from Cinven, Permira and Texas Pacific Group, according to Reuters. Such a sale could generate anywhere from Euro 4 billion to Euro 5.5 billion.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />